ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Longitudinal MRI findings in patients with newly diagnosed glioblastoma after intraoperative radiotherapy
Journal of Neuroradiology
◽
10.1016/j.neurad.2019.01.090
◽
2020
◽
Vol 47
(2)
◽
pp. 166-173
Author(s):
Alex Förster
◽
Johannes Böhme
◽
Máté E. Maros
◽
Stefanie Brehmer
◽
Marcel Seiz-Rosenhagen
◽
...
Keyword(s):
Intraoperative Radiotherapy
◽
Newly Diagnosed
◽
Mri Findings
◽
Longitudinal Mri
◽
Newly Diagnosed Glioblastoma
Download Full-text
Related Documents
Cited By
References
Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma (INTRAGO): An Open-Label, Dose-Escalation Phase I/II Trial
Neurosurgery
◽
10.1093/neuros/nyy018
◽
2018
◽
Vol 84
(1)
◽
pp. 41-49
◽
Cited By ~ 10
Author(s):
Frank A Giordano
◽
Stefanie Brehmer
◽
Bettina Mürle
◽
Grit Welzel
◽
Elena Sperk
◽
...
Keyword(s):
Phase I
◽
Dose Escalation
◽
Intraoperative Radiotherapy
◽
Newly Diagnosed
◽
Open Label
◽
Label Dose
◽
Newly Diagnosed Glioblastoma
Download Full-text
RTHP-05. INTRAOPERATIVE RADIOTHERAPY (IORT) USING LOW-ENERGY X-RAYS IN A COHORT OF PREDOMINANTLY INCOMPLETELY RESECTED NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (INTRAGO TRIAL)
Neuro-Oncology
◽
10.1093/neuonc/now212.731
◽
2016
◽
Vol 18
(suppl_6)
◽
pp. vi174-vi175
◽
Cited By ~ 1
Author(s):
Frank Anton Giordano
◽
Stefanie Brehmer
◽
Bettina Mürle
◽
Grit Welzel
◽
Elena Sperk
◽
...
Keyword(s):
Glioblastoma Multiforme
◽
Intraoperative Radiotherapy
◽
Low Energy
◽
X Rays
◽
Newly Diagnosed
◽
Newly Diagnosed Glioblastoma
Download Full-text
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
Yearbook of Neurology and Neurosurgery
◽
10.1016/j.yneu.2011.04.060
◽
2011
◽
Vol 2011
◽
pp. 141-143
Author(s):
J. Uhm
Keyword(s):
Epidermal Growth Factor Receptor
◽
Growth Factor
◽
Epidermal Growth Factor
◽
Growth Factor Receptor
◽
Progression Free Survival
◽
Newly Diagnosed
◽
Peptide Vaccination
◽
Free Survival
◽
Newly Diagnosed Glioblastoma
◽
Epidermal Growth
Download Full-text
Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
Yearbook of Neurology and Neurosurgery
◽
10.1016/j.yneu.2011.04.050
◽
2011
◽
Vol 2011
◽
pp. 143-144
Author(s):
J. Uhm
Keyword(s):
Maintenance Therapy
◽
Phase I
◽
Newly Diagnosed
◽
Newly Diagnosed Glioblastoma
◽
Concomitant Radiotherapy
Download Full-text
A Study to Evaluate the Safety of 2-OHOA Added to Standard of Care in Newly-diagnosed Glioblastoma Patients
Case Medical Research
◽
10.31525/ct1-nct03867123
◽
2019
◽
Author(s):
Keyword(s):
Standard Of Care
◽
Newly Diagnosed
◽
Newly Diagnosed Glioblastoma
Download Full-text
Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Case Medical Research
◽
10.31525/ct1-nct04047706
◽
2019
◽
Author(s):
Keyword(s):
Radiation Therapy
◽
Newly Diagnosed
◽
Newly Diagnosed Glioblastoma
Download Full-text
Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
Case Medical Research
◽
10.31525/ct1-nct04019262
◽
2019
◽
Author(s):
Keyword(s):
Radiation Therapy
◽
Newly Diagnosed
◽
Short Course
◽
Newly Diagnosed Glioblastoma
Download Full-text
Faculty Opinions recommendation of Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1166601.627611
◽
2009
◽
Author(s):
Wolfgang Wick
◽
Markus Weiler
Keyword(s):
Overall Survival
◽
Newly Diagnosed
◽
Translational Study
◽
Newly Diagnosed Glioblastoma
Download Full-text
Faculty Opinions recommendation of The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.12047960.13188059
◽
2011
◽
Author(s):
David Schiff
◽
Roger Abounader
Keyword(s):
Radiation Therapy
◽
Newly Diagnosed
◽
Newly Diagnosed Glioblastoma
Download Full-text
Faculty Opinions recommendation of Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718058732.793486575
◽
2013
◽
Author(s):
Joachim Baehring
◽
Kevin Becker
Keyword(s):
Radiation Therapy
◽
Maintenance Therapy
◽
Promoter Hypermethylation
◽
Newly Diagnosed
◽
Mgmt Promoter
◽
Newly Diagnosed Glioblastoma
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close